Abstract Background Interstitial lung diseases (ILDs) are associated with a high burden of
disease. However, data on the prognostic impact of comorbidities and comorbidity-related …

Background Interstitial lung disease (ILD) is a heterogeneous group of mainly chronic lung
diseases differing in disease course and prognosis. For most subtypes, evidence on …

Despite a number of prospective registries conducted in past years, the current
epidemiology of interstitial lung diseases (ILD) is still not well defined, particularly regarding …

Fibrosing lung disorders include a large number of diseases with diverse behaviour.
Patients can die because of the progression of their illness, remain stable or even improve …

Background Comorbidities are frequent and have been associated with poor quality of life,
increased hospitalizations, and mortality in patients with interstitial lung disease (ILD) …

Introduction Evidence about the economic burden related to interstitial lung diseases (ILDs)
and the cost-driving factors is sparse. In the knowledge that distinct comorbidities affect the …

Background Prognostic factors have yet to be established for patients with interstitial lung
disease (ILD). We aimed to clarify whether the Charlson Comorbidity Index score (CCIS) …

Background Current data on incidence of interstitial lung diseases (ILDs) are sparse and
concerns about an increasing trend have been raised. We examined incidence rates (IRs) of …

Background The economic burden of interstitial lung disease (ILD) is unknown, limiting
informed resource allocation and planning. We sought to conduct the first systematic review …

ABSTRACT Introduction: Interstitial lung diseases (ILDs) represent a heterogeneous group
of rare disorders that include more than 200 entities, mostly associated with high mortality. In …